Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $87.9197 (-4.71%) ($85.7791 - $91.1745) on Thu. Jul. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.87% (three month average) | RSI | 50 | Latest Price | $87.9197(-4.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(49%) IWD(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.935% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.935% (StdDev 1.87%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
Resistance Level | $91.68 | 5 Day Moving Average | $92.39(-4.84%) | 10 Day Moving Average | $92.98(-5.44%) | 20 Day Moving Average | $91.68(-4.1%) | To recent high | -14.5% | To recent low | 0% | Market Cap | $155.115b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |